Literature DB >> 23585699

Divergent synthesis of triazine dendrimers using a trimethylene-dipiperidine linker that increases efficiency, simplifies analysis, and improves product solubility.

Meredith A Mintzer1, Lisa M Perez, Eric E Simanek.   

Abstract

To combine benefits stemming from the high nucleophilicity of piperidine and the flexibility afforded by aliphatic triamine linkers, a trimethylene-dipiperidine linker has been used to synthesize triazine dendrimers using a divergent route. The cyclic, secondary amine of the linker reacts with monochlorotriazine monomer units, 1, leading to a dendrimer growth strategy that requires two-steps-per-generation. This strategy reduces the number of steps required for synthesis by 50%. The new linker also reduces complexity in the NMR spectra because rotational isomerism observed in linkers with primary amines is not present. In addition, the final products contain no interior hydrogen-bond donating groups. The high solubility observed in organic solvents for protected dendrimers is attributed to this factor and the inherent flexibility provided by the linker. Gas phase simulation suggests that globular structure emerges after generation three, wherein the core of the dendrimer is effectively shielded from solvent.

Entities:  

Year:  2010        PMID: 23585699      PMCID: PMC3622261          DOI: 10.1016/j.tetlet.2009.12.048

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  21 in total

1.  About Dendrimers: Structure, Physical Properties, and Applications.

Authors:  A. W. Bosman; H. M. Janssen; E. W. Meijer
Journal:  Chem Rev       Date:  1999-07-14       Impact factor: 60.622

2.  Chemoselective building blocks for dendrimers from relative reactivity data.

Authors:  Mackay B Steffensen; Eric E Simanek
Journal:  Org Lett       Date:  2003-06-26       Impact factor: 6.005

3.  Synthesis and manipulation of orthogonally protected dendrimers: building blocks for library synthesis.

Authors:  Mackay B Steffensen; Eric E Simanek
Journal:  Angew Chem Int Ed Engl       Date:  2004-10-04       Impact factor: 15.336

4.  Melamine-based organoclay to sequester atrazine.

Authors:  Susan L Neitsch; Kevin J McInnes; Scott A Senseman; G Norman White; Eric E Simanek
Journal:  Chemosphere       Date:  2006-01-05       Impact factor: 7.086

5.  Reduction of drug toxicity using dendrimers based on melamine.

Authors:  Michael F Neerman; Hui-Ting Chen; Alan R Parrish; Eric E Simanek
Journal:  Mol Pharm       Date:  2004 Sep-Oct       Impact factor: 4.939

6.  Dendrimers Based on [1,3,5]-Triazines.

Authors:  Mackay B Steffensen; Emily Hollink; Frank Kuschel; Monika Bauer; Eric E Simanek
Journal:  J Polym Sci A Polym Chem       Date:  2006-06-01       Impact factor: 2.702

7.  Identification of Diamine Linkers with Differing Reactivity and their Application in the Synthesis of a Melamine Dendrimers.

Authors:  Karlos X Moreno; Eric E Simanek
Journal:  Tetrahedron Lett       Date:  2008-02-11       Impact factor: 2.415

8.  Intercepting the synthesis of triazine dendrimers with nucleophilic pharmacophores: a general strategy toward drug delivery vehicles.

Authors:  Vincent J Venditto; Kimberly Allred; Clinton D Allred; Eric E Simanek
Journal:  Chem Commun (Camb)       Date:  2009-08-11       Impact factor: 6.222

Review 9.  Dendrimers as versatile platform in drug delivery applications.

Authors:  Sonke Svenson
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

10.  A divergent route towards single-chemical entity triazine dendrimers with opportunities for structural diversity.

Authors:  Hannah Crampton; Emily Hollink; Lisa M Perez; Eric E Simanek
Journal:  New J Chem       Date:  2007-07-01       Impact factor: 3.591

View more
  1 in total

1.  Dendrimers terminated with dichlorotriazine groups provide a route to compositional diversity.

Authors:  Subrata Patra; Brittany Kozura; Adela Y-T Huang; Alan E Enciso; Xiankai Sun; Jer-Tsong Hsieh; Chai-Lin Kao; Hui-Ting Chen; Eric E Simanek
Journal:  Org Lett       Date:  2013-07-19       Impact factor: 6.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.